Protara Therapeutics Free Cash Flow (Quarterly) Analysis

Protara Therapeutics Inc (TARA)

2.91 +0.02 (+0.69%) USD | NASDAQ | May 03, 16:00

2.89 -0.02 (-0.69%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-8.70M
September 30, 2023	-6.598M
June 30, 2023	-9.41M
March 31, 2023	-12.89M
December 31, 2022	-5.032M
September 30, 2022	-5.43M
June 30, 2022	-5.143M
March 31, 2022	-10.97M

Date	Value
December 31, 2021	-6.951M
September 30, 2021	-6.137M
June 30, 2021	-9.80M
March 31, 2021	-12.21M
December 31, 2020	-7.277M
September 30, 2020	-3.894M
June 30, 2020	-5.727M
March 31, 2020	-7.393M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-12.89M

Minimum

Mar 2023

-3.894M

Maximum

Sep 2020

-7.723M

Average

-7.114M

Median

Free Cash Flow (Quarterly) Benchmarks